Indolepyruvic acid

Drug Profile

Indolepyruvic acid

Alternative Names: Indole-3-pyruvic acid; IPA

Latest Information Update: 23 Jul 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Polifarma
  • Class Indoles; Small molecules
  • Mechanism of Action Excitatory amino acid antagonists; Melanocortin receptor agonists; Melatonin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Anxiety disorders; Major depressive disorder; Sleep disorders

Most Recent Events

  • 23 Jul 2003 No development reported - Phase-II for Anxiety disorders in Italy (PO)
  • 23 Jul 2003 No development reported - Phase-II for Depression in Italy (PO)
  • 23 Jul 2003 No development reported - Phase-II for Sleep disorders in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top